African-European HIV vaccine clinical trials come to a grinding halt
HQ Team December 11, 2023: African researchers and European scientists, conducting clinical trials for an HIV vaccine, have halted further vaccinations after they turned
HQ Team December 11, 2023: African researchers and European scientists, conducting clinical trials for an HIV vaccine, have halted further vaccinations after they turned
HQ Team December 9, 2023: An “unprecedented” outbreak of anthrax, with 684 suspected human cases, has been reported from Zambia, according to the
HQ Team December 9, 2023: The Centers for Disease Control and Prevention (CDC) has issued a health advisory after three people died following
HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US
HQ Team December 8, 2023: The current global risk from cholera is “very high” with vaccines running short of demand, the World Health
HQ Team December 8, 2023: A record number of 2,456 fuel lobbyists, tied to the world’s biggest polluting oil and gas firms and
HQ Team December 7, 2023: Global nations have raised $83.3 billion so far for financing climate change, according to COP28, the UN Climate
HQ Team December 7, 2023: AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to
HQ Team December 7, 2023: About 40 million women, or one-third, were likely to have a long-term childbirth-related health problem, which is often
HQ Team December 7, 2023: Climate funds sanctioned by nations globally for Indigenous Peoples and local communities tend to “evaporate” when channelled through